Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
2 clinical trials · Condition
◉ Watch Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma (NCT03430687) | University of California, San Francisco | 2018-06-01 |
| Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer (NCT02844816) | National Cancer Institute (NCI) | 2017-03-13 |
Track Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.